ProPhase Labs, Inc. cotiza a 0.01 USD y tiene una capitalización bursátil de $155926. En los últimos 12 meses ha facturado $3M con un margen de flujo de caja libre del -192.0%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement…
| Periodo | 2026-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | — | $-0.81 | $-1.20 | $-15.90 |
| Estimado | — | $-1.50 | $-1.80 | $-2.40 |
| Sorpresa | — | +46.0% | +33.3% | -562.5% |
| Métrica | PRPH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 31.9% | 57.0% | -25.2% |
| Operating Margin | -415.4% | -38.6% | -376.7% |
| Net Margin | -339.3% | -33.6% | -305.8% |
| FCF Margin | -192.0% | -13.9% | -178.2% |
| ROE | -420.3% | -40.4% | -379.9% |
| ROA | -24.6% | -32.0% | +7.4% |
| Current Ratio | 0.06 | 2.84 | -2.78 |
| Debt / Equity | — | 0.28 | — |